Top 10 ETF gainers and losers for Jan 27, 2016

The data was compiled using CapitalCube’s ETF Screener

Top 10 ETF gainers with assets of more than $25 million as of Jan 27, 2016. (Leveraged)

Symbol Company 1 Week Volatility (%) 1 Day Price Return (%) Monthly Fund Flows ($ Millions) Net Assets ($ Millions) Average Daily Volume (Thousands) Net Expense Ratio (%)
LABD   Direxion Daily S&P Biotech Bear 3x Shares   7.27 13.62 -7.24 32.67 702.02 0.95
RUSL   Direxion Daily Russia Bull 3x Shares   11.22 8.62 -3.28 185.83 1444.81 0.95
UVXY   ProShares Ultra VIX Short-Term Futures ETF   10.23 8.30 32.74 560.36 24259.83 0.95
TVIX   VelocityShares Daily 2x VIX Short Term ETN   10.24 8.12 -4.97 294.32 25624.33 1.65
SQQQ   ProShares UltraPro Short QQQ   5.61 7.49 -43.36 374.00 8641.92 0.95
UWTI   VelocityShares 3x Long Crude ETN   15.94 6.04 -139.32 897.68 33768.37 1.35
JNUG   Direxion Daily Junior Gold Miners Index Bull 3x Shares   4.28 5.50 -7.47 105.10 1119.34 0.95
NUGT   Direxion Daily Gold Miners Bull 3x Shares   4.50 5.24 -7.87 642.77 6658.73 0.95
UCO   ProShares Ultra Bloomberg Crude Oil   10.80 4.77 -84.59 786.44 8572.87 0.95
SRTY   ProShares UltraPro Short Russell2000   5.50 4.33 -13.96 51.26 1232.25 0.95
TZA   Direxion Daily Small Cap Bear 3X Shares   5.43 4.22 -30.24 386.17 4012.83 0.95

 

More on the top 2 ETF gainers in the  leveraged category
  1. The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.
  2. The Daily Russia Bull 3x Shares seeks daily investment results, before fees and expenses, of 300% of the price performance of the DAX Global Russia+ Index. The DAX Global Russia+ Index is an index comprised of the most liquid Russian ADRs/GDRs and local shares, screening for high liquidity only, and capping the number of securities at 45.

Top 10 ETF losers with assets of more than $25 million as of Jan 27, 2015 

( Leveraged)

Symbol Company 1 Day Price Return (%) Net Assets ($ Millions) Net Expense Ratio (%) 1 Week Volatility (%) Average Daily Volume (Thousands) Monthly Fund Flows ($ Millions)
LABU   Direxion Daily S&P Biotech Bull 3x Shares   -13.21 142.79 0.95 7.12 2617.79 -21.01
RUSS   Direxion Daily Russia Bear 3x Shares   -9.17 34.60 0.95 10.98 413.90 -19.87
UBIO   ProShares UltraPro NASDAQ Biotechnology   -9.12 49.09 0.95 6.72 123.13 -2.09
TQQQ   ProShares UltraPro QQQ   -7.44 1370.00 0.95 5.62 4331.81 -32.00
DWTI   VelocityShares 3x Inverse Crude ETN   -6.95 217.73 1.35 16.91 1341.36 50.48
TECL   Direxion Daily Technology Bull 3X Shares   -6.21 180.32 0.95 5.03 199.32 -11.05
BIB   ProShares Ultra Nasdaq Biotechnology   -6.13 753.61 0.95 4.40 1064.91 -26.09
DRN   Direxion Daily Real Estate Bull 3x Shares   -5.63 105.76 0.95 5.07 124.94 4.56
JDST   Direxion Daily Junior Gold Miners Index Bear 3x Shares   -5.57 32.68 0.95 4.18 951.03 -21.18
DUST   Direxion Daily Gold Miners Bear 3x Shares   -5.53 181.67 0.95 4.40 8487.57 -28.00

More on the top 2 ETF losers in the  leveraged category:

  1. The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.
  2. The Daily Russia Bear 3x Shares seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the price performance of the DAX Global Russia+ Index. The DAX Global Russia+ Index is an index comprised of the most liquid Russian ADRs/GDRs and local shares, screening for high liquidity only, and capping the number of securities at 45.

Top 10 ETF gainers with assets of more than $25 million as of Jan 27, 2016. (NO Leverage)

Symbol Company Average Daily Volume (Thousands) Net Assets ($ Millions) 1 Week Volatility (%) 1 Day Price Return (%) Net Expense Ratio (%) Monthly Fund Flows ($ Millions)
VIXY   ProShares VIX Short-Term Futures ETF   3211.81 105.28 5.06 4.16 0.85 2.94
VXX   iPATH S&P 500 VIX Short-Term Futures ETN   74273.57 755.03 5.11 4.12 0.89 -51.62
UAE   iShares MSCI UAE Capped ETF   11.03 25.22 2.65 3.82 0.62 0.08
BNO   United States Brent Oil Fund LP   151.02 82.49 5.03 3.71 0.75 -0.52
ERUS   iShares MSCI Russia Capped ETF   431.01 209.49 4.07 3.25 0.62 -23.20
RSX   Market Vectors Russia ETF   12849.25 1736.00 3.87 3.01 0.63 -166.00
OIL   iPath Goldman Sachs Crude Oil Total Return Index ETN   4488.40 746.50 8.46 2.79 0.75 -22.29
KBE   SPDR S&P Bank ETF   2195.17 2674.00 2.38 2.75 0.35 -297.00
MLTI   Credit Suisse X-Links Multi-Asset High Income ETN   1.00 25.57 1.11 2.46 0.84 -0.52
USL   United States 12 Month Oil Fund LP   96.20 70.53 3.68 2.46 0.60 1.37

 More on the top 2 ETF gainers in the non leveraged category:

  1. The CBOE Volatility Index (VIX) is a widely followed measure of the expected volatility of the S&P 500. Since the VIX is not directly investable S&P 500 volatility exposure is often achieved through VIX futures. Each of the VIX futures indexes measures the movements of a combination of VIX futures and is designed to track changes in the expectation for VIX over a specific time window in the future. As a result the S&P 500 VIX Short-Term Futures Index and VIXY can be expected to perform differently than the VIX.
  2. The S&P 500 VIX Short-Term Futures Index TR is designed to provide access to equity market volatility through CBOE Volatility Index (the “VIX Index”) futures. Specifically, the S&P 500 VIX Short-Term Futures Index TR offers exposure to a daily rolling long position in the first and second month VIX futures contracts and reflects the implied volatility of the S&P 500 Index at various points along the volatility forward curve. The index futures roll continuously throughout each month from the first month VIX futures contract into the second month VIX futures contract. A direct investment in VIX (commonly referred to as spot VIX) is not possible. The S&P 500 VIX Short-Term Futures Index TR holds VIX futures contracts, which could involve roll costs and exhibit different risk and return characteristics. Investments offering volatility exposure can have various uses within a portfolio including hedging, directional, or arbitrage strategies and are typically short or medium-term in nature.

Top 10 ETF losers with assets of more than $25 million as of Oct 23, 2014. (No Leverage)

Symbol Company 1 Week Volatility (%) Net Assets ($ Millions) Net Expense Ratio (%) Monthly Fund Flows ($ Millions) 1 Day Price Return (%) Average Daily Volume (Thousands)
SBIO   ALPS Medical Breakthroughs ETF   2.66 168.21 0.50 -2.62 -5.15 119.52
XBI   SPDR S&P Biotech ETF   2.47 2257.00 0.35 -38.00 -4.55 4591.67
SGG   iPath Bloomberg Sugar Subindex Total Return ETN   2.02 57.96 0.75 -3.65 -4.12 58.24
XPH   SPDR S&P Pharmaceuticals ETF   2.24 670.82 0.35 -46.80 -4.07 204.94
FBT   First Trust NYSE Arca Biotechnology Index Fund   2.39 3437.00 0.58 49.00 -3.72 244.31
PTH   PowerShares DWA Healthcare Momentum Portfolio   2.27 259.22 0.60 6.78 -3.48 57.13
FLGE   Credit Suisse FI Large Cap Growth Enhanced ETN   2.98 620.04 0.85 3.66 -3.19 6.29
PSCH   PowerShares S&P SmallCap Health Care Portfolio   1.83 272.79 0.29 20.63 -3.10 39.34
IBB   iShares Nasdaq Biotechnology ETF   2.26 8122.00 0.48 -271.00 -3.08 2548.31
PJP   Powershares Dynamic Pharmaceuticals Portfolio   2.08 1581.00 0.58 -83.00 -3.03 249.90

More on the top 2 ETF losers in the non leveraged category:

  1. The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
  2. The SPDR S&P Biotech ETF before expenses seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index (ticker: SPSIBITR).

Disclaimer

Leave a Comment